The initial clinical site is The University of Arizona Medical Center in Tucson, and the trial aims to capture preliminary safety and effectiveness data of the Neuro-Spinal Scaffold. In preclinical studies, the scaffold promoted cell adhesion, neurite sprouting, the growth of remodeled spinal cord tissue containing myelinated axons and improved motor function.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
